Belsky Marc 4
4 · Kezar Life Sciences, Inc. · Filed Apr 1, 2025
Insider Transaction Report
Form 4
Belsky Marc
Chief Financial Officer
Transactions
- Award
Employee Stock Option (right to buy)
2025-03-27+4,800→ 12,000 totalExercise: $6.30Exp: 2034-07-10→ Common Stock (4,800 underlying)
Footnotes (1)
- [F1]On July 11, 2024, the Reporting Person was granted an option to purchase 12,000 shares of common stock that vests on July 11, 2025, pending the achievement of non-financial performance criteria and continuing service through such date. On March 4, 2025, the Company's Compensation Committee (the "Committee") certified that certain of the non-financial performance criteria were achieved for 7,200 shares underlying the option. On March 27, 2025, the Committee certified that certain of the non-financial performance criteria were achieved for the remaining 4,800 shares underlying the option and as such, the entire option will vest on July 11, 2025, provided the Reporting Person continues to provide service through such date.